Multiple myeloma trials in New Zealand

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  Where

  Auckland, Dunedin, Tauranga

  Age

  18 years and over

  People

  810 worldwide

  Run by

  Celgene

  See details and how to joinNCT05519085
• Phase 3Taking people
  A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

  Where

  Auckland, Grafton, Hamilton, Newtown

  Age

  18 years and over

  People

  1,060 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05623020 · EU 2024-514139-50-00
• Phase 2Enrolling by invitation
  International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

  Where

  Auckland, Wellington

  Age

  18 years and over

  People

  70 worldwide

  Run by

  Sanofi

  See details and how to joinNCT05669989
• Phase 3Taking people
  A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

  Where

  Auckland, Hamilton, Milford, Newtown, Palmerston North, Roslyn, Takapuna, Wellington

  Age

  18 years and over

  People

  893 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05020236 · EU 2023-509208-14-00